ECSP056089A - Proceso para la sintesis de 3-ciano-6-alcoxi-7-nitro-4-quinolonas - Google Patents

Proceso para la sintesis de 3-ciano-6-alcoxi-7-nitro-4-quinolonas

Info

Publication number
ECSP056089A
ECSP056089A EC2005006089A ECSP056089A ECSP056089A EC SP056089 A ECSP056089 A EC SP056089A EC 2005006089 A EC2005006089 A EC 2005006089A EC SP056089 A ECSP056089 A EC SP056089A EC SP056089 A ECSP056089 A EC SP056089A
Authority
EC
Ecuador
Prior art keywords
cyano
nitro
anthranilate
alcoxi
ciano
Prior art date
Application number
EC2005006089A
Other languages
English (en)
Inventor
Scott Mason Duncan
Miguel Angel Pagan
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of ECSP056089A publication Critical patent/ECSP056089A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se proporciona un proceso para la preparación de intermediarios de 3-ciano-6-alcoxi-7-nitro-4-quinolona útiles para la preparación de inhibidores de proteína tirosina cinasa (PTK) los cuales son útiles en el tratamiento del cáncer de la fórmula, donde R es alquilo(C1-C3) preparado mediante la reacción de un antranilato sustituido con N,N-dimetilformamida dimetilacetal para obtener una N,N-dimetilamidina la cual es condensada con t-butilcianoacetato para obtener un N-(2-ciano-2-t-butoxicarbonilvinil)antranilato, el cual es hidrolizado para producir un N-(2-ciano-2-carboxivinil)antranilato seguido por descarboxilación para obtener N-(2-ciano-2-carboxivinil)antranilato seguido por ciclización para obtener un 3-ciano-6-alcoxi-7-nitro-4-quinolona.
EC2005006089A 2003-04-09 2005-10-07 Proceso para la sintesis de 3-ciano-6-alcoxi-7-nitro-4-quinolonas ECSP056089A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46164703P 2003-04-09 2003-04-09

Publications (1)

Publication Number Publication Date
ECSP056089A true ECSP056089A (es) 2006-03-01

Family

ID=33299849

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2005006089A ECSP056089A (es) 2003-04-09 2005-10-07 Proceso para la sintesis de 3-ciano-6-alcoxi-7-nitro-4-quinolonas

Country Status (21)

Country Link
US (1) US6933388B2 (es)
EP (1) EP1611103A1 (es)
JP (1) JP2006522810A (es)
KR (1) KR20050120788A (es)
CN (1) CN100376558C (es)
AR (1) AR043988A1 (es)
AU (1) AU2004230864A1 (es)
BR (1) BRPI0409134A (es)
CA (1) CA2521294A1 (es)
CL (1) CL2004000758A1 (es)
CO (1) CO5640089A2 (es)
CR (1) CR7991A (es)
EC (1) ECSP056089A (es)
EG (1) EG24122A (es)
MX (1) MXPA05010685A (es)
NI (1) NI200500175A (es)
NO (1) NO20054375L (es)
RU (1) RU2333909C2 (es)
TW (1) TW200504024A (es)
UA (1) UA80607C2 (es)
WO (1) WO2004092138A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101723854A (zh) * 2008-10-24 2010-06-09 上海特化医药科技有限公司 6-取代氨基-3-氰基喹啉类化合物的制备方法及其中间体
CN111116416B (zh) * 2019-12-30 2021-03-23 中国农业大学 一种β-氨基丙烯腈类化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1207771A (en) * 1968-03-18 1970-10-07 Warner Lambert Pharmaceutical Anti-virally active quinoline derivatives
EP0876345B1 (en) * 1995-10-16 2004-08-18 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic compounds as h+-atpases
UA73073C2 (uk) * 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines
HU230728B1 (hu) * 1998-09-29 2017-12-28 Wyeth Holdings Llc Szubsztituált 3-cianokinolinok mint protein tirozin kinázok inhibitorai

Also Published As

Publication number Publication date
CA2521294A1 (en) 2004-10-28
CN1771230A (zh) 2006-05-10
CL2004000758A1 (es) 2005-02-04
AU2004230864A1 (en) 2004-10-28
UA80607C2 (en) 2007-10-10
CR7991A (es) 2006-05-31
NI200500175A (es) 2006-05-04
EP1611103A1 (en) 2006-01-04
WO2004092138A1 (en) 2004-10-28
MXPA05010685A (es) 2005-12-12
CN100376558C (zh) 2008-03-26
NO20054375L (no) 2005-10-12
RU2333909C2 (ru) 2008-09-20
US6933388B2 (en) 2005-08-23
KR20050120788A (ko) 2005-12-23
EG24122A (en) 2008-07-06
JP2006522810A (ja) 2006-10-05
US20040204587A1 (en) 2004-10-14
CO5640089A2 (es) 2006-05-31
BRPI0409134A (pt) 2006-03-28
AR043988A1 (es) 2005-08-17
TW200504024A (en) 2005-02-01
RU2005134653A (ru) 2006-03-27

Similar Documents

Publication Publication Date Title
CY1123817T1 (el) Μεθοδος για την παρασκευη ενωσεων που ειναι χρησιμες ως αναστολεις sglt
EA202092558A1 (ru) КРИСТАЛЛИЧЕСКАЯ ФОРМА ИНГИБИТОРА c-MET, ЕГО СОЛЕВАЯ ФОРМА И СПОСОБ ИХ ПОЛУЧЕНИЯ
EA201000113A1 (ru) Пиразольные соединения
EA201200669A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
EA200800760A1 (ru) ПИРИДОПИРИМИДИНОНОВЫЕ ИНГИБИТОРЫ PI3Kα
CY1113992T1 (el) Αναλογα κιναζολινης ως αναστολεις υποδοχεων κινασης της τυροσινης
EA201071264A1 (ru) Аминодигидротиазиновые производные в качестве ингибиторов bace для лечения болезни альцгеймера
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
EA200501504A1 (ru) Лиганды каннабиноидных рецепторов и их применение
EA201171489A1 (ru) Аминопиримидиновые противораковые соединения
EA201070186A1 (ru) Способы и соединения, предназначенные для получения ингибиторов котранспортера натрий-глюкозы 2 типа
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
EA201100517A1 (ru) Способ получения дабигатрана и его промежуточные соединения
CY1111733T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
EA200301142A1 (ru) Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6
GT200500296A (es) Sintesis asimetrica de derivados del dehidrobenzofurano
EA200701588A1 (ru) Способы получения замещённых фенилпиразолмочевин
EA201891772A1 (ru) Трифторацетатная соль агониста tlr7 и ее кристаллическая форма b, способы получения и использование
EA200970936A1 (ru) СОЕДИНЕНИЯ ПИРИДО[2,3-d]ПИРИМИДИН-7-ОНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3K-АЛЬФА ДЛЯ ЛЕЧЕНИЯ РАКА
EA200600605A1 (ru) Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств
CY1115729T1 (el) Τρικυκλικη ενωση και φαρμακευτικη χρηση αυτης
ECSP055693A (es) Proceso para la síntesis de intermediarios útiles para la síntesis de inhibidores de la tubulina
NI200500175A (es) Proceso para la sintesis de 3-ciano-6-alcoxi-7-nitro-4-quinolonas
DK1745010T3 (da) Substituerede cyklohexyl-1,4-diaminderivater